Turn Therapeutics Inc.

TTRX · Nasdaq · SIC 2834: Pharmaceutical Preparations
20
SEC Filings

Business Summary

PART I Unless the context otherwise requires, for purposes of this section, the terms we, us, or the Company or Turn Therapeutics refer to Turn Therapeutics Inc. Overview Turn Therapeutics is developing non-systemic, non-biologic topical immunomodulators for inflammatory skin disease. Our lead program, GX-03, is being studied for moderate-to-severe eczema based on preclinical evidence of cytokine inhibition and reduced eczema severity, as well as a favorable real-world tolerability record from p...

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionTTRXdiscussed_in_filing Cybersecurity
topic_mentionTTRXdiscussed_in_filing Trusted Computing
topic_mentionTTRXdiscussed_in_filing Blockchain & Crypto
topic_mentionTTRXdiscussed_in_filing Capital Expenditure
topic_mentionTTRXdiscussed_in_filing Regulation
topic_mentionTTRXdiscussed_in_filing Automotive
topic_mentionTTRXdiscussed_in_filing Healthcare & Bio
topic_mentionTTRXdiscussed_in_filing Platform & Ecosystem
topic_mentionTTRXdiscussed_in_filing Sovereign & Government
topic_mentionTTRXdiscussed_in_filing Cybersecurity
topic_mentionTTRXdiscussed_in_filing Trusted Computing
topic_mentionTTRXdiscussed_in_filing Blockchain & Crypto
topic_mentionTTRXdiscussed_in_filing Capital Expenditure
topic_mentionTTRXdiscussed_in_filing Regulation
topic_mentionTTRXdiscussed_in_filing Automotive
topic_mentionTTRXdiscussed_in_filing Healthcare & Bio
topic_mentionTTRXdiscussed_in_filing Platform & Ecosystem
topic_mentionTTRXdiscussed_in_filing Sovereign & Government
topic_mentionTTRXdiscussed_in_filing Cybersecurity
topic_mentionTTRXdiscussed_in_filing Trusted Computing

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-312025-12-310001213900-26-037505EDGAR74K words

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-132025-09-300001213900-25-109586EDGAR22K words

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-310001213900-26-037470EDGAR1K words
2026-03-240001213900-26-033233EDGAR—
2026-02-170001213900-26-016916EDGAR—
2026-02-090001213900-26-013490EDGAR—
2026-01-120001213900-26-003153EDGAR—
2026-01-070001213900-26-002173EDGAR—
2025-11-130001213900-25-109580EDGAR—
2025-11-120001213900-25-108655EDGAR—
2025-11-040001213900-25-106265EDGAR—
2025-10-300001104659-25-104028EDGAR—

20 total filings indexed. 8 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0002023016
TickerTTRX
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: fbbc7c4309210315e8dbfacc73f595f28c8c7f9c38d7ea89c8760021f948ac88
parent: 11a0b3b8944475f9bc15745e628586b4aee5d03fb10492f2d902c589f6a83a36
content hash: 4262bc0ddd84e4246dee0991e77f533178dd48a486f44da8569460c500203417
signed: 2026-04-13T04:47:54.975Z
sources: 2 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf